Evidence map›Paper›PMID 33780656›Full record

SynthesisThe Lancet. Public health2021

Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

Chiedozie Arum, Hannah Fraser, Andreea Adelina Artenie, Sandra Bivegete, Adam Trickey, Michel Alary, Jacquie Astemborski, Jennifer Iversen, Aaron G Lim, Louis MacGregor and 14 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Lancet. Public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Barriers and facilitators to hepatitis C screening and treatment for people with lived experience of homelessness: A mixed-methods systematic review.Health expectations : an international journal of public participation in health care and health policy · 2022
    Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Article
  13. First year of ongoing invasiveEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Chiedozie ArumPopulation Health Sciences, University of Bristol, Bristol, UK.
Hannah FraserPopulation Health Sciences, University of Bristol, Bristol, UK.
Andreea Adelina ArteniePopulation Health Sciences, University of Bristol, Bristol, UK.
Sandra BivegetePopulation Health Sciences, University of Bristol, Bristol, UK.
Adam TrickeyPopulation Health Sciences, University of Bristol, Bristol, UK.
Michel AlaryCentre de recherche du CHU de Québec, Université Laval, Quebec City, QC, Canada; Département de médecine sociale et préventive, Université Laval, Quebec City, QC, Canada; Institut national de santé publique du Québec, Québec, QC, Canada.
Jacquie AstemborskiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Jennifer IversenKirby Institute for Infection and Immunity, UNSW Sydney, NSW, Australia.
Aaron G LimPopulation Health Sciences, University of Bristol, Bristol, UK.
Louis MacGregorPopulation Health Sciences, University of Bristol, Bristol, UK.
Meghan MorrisDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Jason J OngPopulation Health Sciences, University of Bristol, Bristol, UK; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Lucy PlattFaculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Rachel Sack-DavisBurnet Institute, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Daniela K van SantenBurnet Institute, Melbourne, VIC, Australia; Department of Infectious Disease Research and Prevention, Public Health Service of Amsterdam, Amsterdam, Netherlands.
Sunil S SolomonDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Vana SypsaDepartment of Hygiene, Epidemiology and Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Jorge ValenciaHarm Reduction Unit "SMASD", Department of Addictions and Mental Health, Madrid, Spain.
Wijnand Van Den BoomBurnet Institute, Melbourne, VIC, Australia.
Josephine G WalkerPopulation Health Sciences, University of Bristol, Bristol, UK.
Zoe WardPopulation Health Sciences, University of Bristol, Bristol, UK.
Jack StonePopulation Health Sciences, University of Bristol, Bristol, UK. Electronic address: jack.stone@bristol.ac.uk.
Peter VickermanPopulation Health Sciences, University of Bristol, Bristol, UK.
Homelessness, HIV, and HCV Review Collaborative Group

Funding

Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDSU01DA038886 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI DEBECK, KORA, HAYASHI, KANNA · 2015 to 2024
$12.1M
Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) StudyR01DA047952 · NIDA · UNIVERSITY OF KENTUCKY · PI HAVENS, JENNIFER R · 2018 to 2023
$8.7M
Expanding Medication Assisted Therapy in Ukraine (ExMAT)R01DA033679 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2012 to 2021
$6.4M
Individual, Network and Spatial Drivers of HIV and HCV among PWID in IndiaR01DA041736 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SOLOMON, SUNIL SUHAS · 2016 to 2021
$5.0M
Optimizing HIV prevention portfolios targeting people who inject drugs using dynamic economic modelingR01AI147490 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARTIN, NATASHA · 2019 to 2022
$2.3M
Modeling Structural HIV Determinants in Substance Users and related populationsR01DA037773 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARTIN, NATASHA, STRATHDEE, STEFFANIE A. · 2015 to 2017
$1.4M
Understanding the interpersonal context of HIV/HCV risk within injecting dyadsK01DA037802 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MORRIS, MEGHAN D · 2014 to 2018
$913k
Informing hepatitis C virus elimination strategies with epidemiological data from highest need populationsR21DA046809 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MORRIS, MEGHAN D · 2019 to 2020
$385k
Medical Research Council MC_UU_00004/03Medical Research Council MR/N00616X/1NIAID NIH HHS R01 AI147490NIDA NIH HHS K01 DA037802NIDA NIH HHS R01 DA033679NIDA NIH HHS R01 DA037773NIDA NIH HHS R01 DA041736NIDA NIH HHS R01 DA047952NIDA NIH HHS R21 DA046809NIDA NIH HHS U01 DA038886
6 · The paper itself

Abstract

backgroundPeople who inject drugs (PWID) are at increased risk for HIV and hepatitis C virus (HCV) infection and also have high levels of homelessness and unstable housing. We assessed whether homelessness or unstable housing is associated with an increased risk of HIV or HCV acquisition among PWID compared with PWID who are not homeless or are stably housed.

methodsIn this systematic review and meta-analysis, we updated an existing database of HIV and HCV incidence studies published between Jan 1, 2000, and June 13, 2017. Using the same strategy as for this existing database, we searched MEDLINE, Embase, and PsycINFO for studies, including conference abstracts, published between June 13, 2017, and Sept 14, 2020, that estimated HIV or HCV incidence, or both, among community-recruited PWID. We only included studies reporting original results without restrictions to study design or language. We contacted authors of studies that reported HIV or HCV incidence, or both, but did not report on an association with homelessness or unstable housing, to request crude data and, where possible, adjusted effect estimates. We extracted effect estimates and pooled data using random-effects meta-analyses to quantify the associations between recent (current or within the past year) homelessness or unstable housing compared with not recent homelessness or unstable housing, and risk of HIV or HCV acquisition. We assessed risk of bias using the Newcastle-Ottawa Scale and between-study heterogeneity using the I

findingsWe identified 14 351 references in our database search, of which 392 were subjected to full-text review alongside 277 studies from our existing database. Of these studies, 55 studies met inclusion criteria. We contacted the authors of 227 studies that reported HIV or HCV incidence in PWID but did not report association with the exposure of interest and obtained 48 unpublished estimates from 21 studies. After removal of duplicate data, we included 37 studies with 70 estimates (26 for HIV; 44 for HCV). Studies originated from 16 countries including in North America, Europe, Australia, east Africa, and Asia. Pooling unadjusted estimates, recent homelessness or unstable housing was associated with an increased risk of acquiring HIV (crude relative risk [cRR] 1·55 [95% CI 1·23-1·95; p=0·0002]; I

interpretationHomelessness and unstable housing are associated with increased risk of HIV and HCV acquisition among PWID. Our findings support the development of interventions that simultaneously address homelessness and unstable housing and HIV and HCV transmission in this population.

fundingNational Institute for Health Research, National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, and Commonwealth Scholarship Commission.

Indexed as

Global HealthHepatitis CHIV InfectionsHousingHumansIll-Housed PersonsRisk AssessmentSubstance Abuse, Intravenous

Identifiers

PMID33780656
PMCPMC8097637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.